Marjolein Breur

Marjolein Breur

Auto-generated profile, based on publicly available information

Marjolein Breur

Department of Child Neurology, Emma Children’s Hospital, Amsterdam University Medical Center, Amsterdam Neuroscience

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2013 in Immunology
Verified
Journal Article
Open access
PDF file
SASandra Amor
Sandra Amor
LPLaura Anna Norma Peferoen
Laura Anna Norma Peferoen
DVDaphne Y. S. Vogel
Daphne Y. S. Vogel
MBMarjolein Breur
Marjolein Breur
PVPaul van der Valk
Paul van der Valk
JNJohannes M. van Noort
Johannes M. van Noort
Summary: Neurodegeneration, the progressive dysfunction and loss of neurons in the central nervous system (CNS), is the major cause of cognitive and motor dysfunction. While neuronal degeneration is well‐known inAlzheimer's andParkinson's diseases, it is also observed in neurotrophic infections, traumatic brain and spinal cord injury, stroke, neoplastic disorders, prion diseases, multiple sclerosis and amyotrophic lateral sclerosis, as well as neuropsychiatric disorders and genetic disorders. A common link between these diseases is chronic activation of innate immune responses including those mediated by microglia, the residentCNSmacrophages. Such activation can trigger neurotoxic pathways leading to progressive degeneration. Yet, microglia are also crucial for controlling inflammatory processes, and repair and regeneration. The adaptive immune response is implicated in neurodegenerative diseases contributing to tissue damage, but also plays important roles in resolving inflammation and mediating neuroprotection and repair. The growing awareness that the immune system is inextricably involved in mediating damage as well as regeneration and repair in neurodegenerative disorders, has prompted novel approaches to modulate the immune system, although it remains whether these approaches can be used in humans. Additional factors in humans include ageing and exposure to environmental factors such as systemic infections that provide additional clues that may be human specific and therefore difficult to translate from animal models. Nevertheless, a better understanding of how immune responses are involved in neuronal damage and regeneration, as reviewed here, will be essential to develop effective therapies to improve quality of life, and mitigate the personal, economic and social impact of these diseases.

1 September 2014 in Immunobiology
Verified
Journal Article
Open access
DVDaphne Y.S. Vogel
Daphne Y.S. Vogel
JGJudith E. Glim
Judith E. Glim
ASAndrea W.D. Stavenuiter
Andrea W.D. Stavenuiter
MBMarjolein Breur
Marjolein Breur
PHPriscilla Heijnen
Priscilla Heijnen
RBRobert H.J. Beelen
Robert H.J. Beelen
Macrophages form a heterogeneous cell population displaying multiple functions, and can be polarized into pro- (M1) or anti-inflammatory (M2) macrophages, by environmental factors. Their activation status reflects a beneficial or detrimental role in various diseases. Currently several in vitro maturation and activation protocols are used to induce an M1 or M2 phenotype. Here, the impact of different maturation factors (NHS, M-CSF, or GM-CSF) and activation methods (IFN-γ/LPS, IL-4, dexamethason, IL-10) on the macrophage phenotype was determined. Regarding macrophage morphology, pro-inflammatory (M1) activation stimulated cell elongation, and anti-inflammatory (M2) activation induced a circular appearance. Activation with pro-inflammatory mediators led to increased CD40 and CD64 expression, whereas activation with anti-inflammatory factors resulted in increased levels of MR and CD163. Production of pro-inflammatory cytokines was induced by activation with IFN-γ/LPS, and TGF-β production was enhanced by the maturation factors M-CSF and GM-CSF. Our data demonstrate that macrophage marker expression and cytokine production in vitro is highly dependent on both maturation and activation methods. In vivo macrophage activation is far more complex, since a plethora of stimuli are present. Hence, defining the macrophage activation status ex vivo on a limited number of markers could be indecisive. From this study we conclude that maturation with M-CSF or GM-CSF induces a moderate anti- or pro-inflammatory state respectively, compared to maturation with NHS. CD40 and CD64 are the most distinctive makers for human M1 and CD163 and MR for M2 macrophage activation and therefore can be helpful in determining the activation status of human macrophages ex vivo.

30 June 2017 in Frontiers in Molecular Neuroscience
Verified
Journal Article
Open access
DRDivya Raj
Divya Raj
ZYZhuoran Yin
Zhuoran Yin
MBMarjolein Breur
Marjolein Breur
JDJanine Doorduin
Janine Doorduin
IHInge R. Holtman
Inge R. Holtman
EBErik Boddeke
Erik Boddeke
Chronic neuroinflammation, which is primarily mediated by microglia, plays an essential role in aging and neurodegeneration. It is still unclear whether this microglia-induced neuroinflammation occurs globally or is confined to distinct brain regions. In this study, we investigated microglia activity in various brain regions upon healthy aging and Alzheimer’s disease (AD)-related pathology in both human and mouse samples. In purified microglia isolated from the aging mouse brain, we found a profound gene expression pattern related to pro-inflammatory processes, phagocytosis, and lipid homeostasis. Particularly in white matter microglia of 24-month-old mice, abundant expression of phagocytic markers including Mac-2, Axl, CD16/32, Dectin1, Cd11c, and Cd36 was detected. In white matter of human brain the first signs of inflammatory activity were already detected during middle age. Quantification of microglial proteins, such as CD68 (commonly associated with phagocytosis) and HLA-DR (associated with antigen presentation), in postmortem human white matter brain tissue showed an age-dependent increase in immunoreactivity already in middle-aged people (53.2 ± 2.0 yr), which was also detectable by non-invasive positron emission tomography (PET) imaging using [11C]-(R)-PK11195, a ligand that binds to activated microglia. Increased microglia activity was also prominently present in the white matter of human early-onset postmortem AD (EOAD) brains. Interestingly, microglia activity in the white matter of late-onset AD (LOAD) CNS was similar to that of the aged clinically-silent AD cases. These data indicate that microglia-induced neuroinflammation is predominant in the white matter of aging mice and humans as well as in EOAD brains. This white matter inflammation may contribute to the progression of neurodegeneration, and have prognostic value for detecting the onset and progression of aging and neurodegeneration.

1 January 2014 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
DVDaphne Ys Vogel
Daphne Ys Vogel
PHPriscilla Dam Heijnen
Priscilla Dam Heijnen
MBMarjolein Breur
Marjolein Breur
HVHelga E de Vries
Helga E de Vries
ATAnton Tj Tool
Anton Tj Tool
CDChristine D Dijkstra
Christine D Dijkstra
In neuroinflammatory diseases, macrophages can play a dual role in the process of tissue damage, depending on their activation status (M1 / M2). M1 macrophages are considered to exert damaging effects to neurons, whereas M2 macrophages are reported to aid regeneration and repair of neurons. Their migration within the central nervous system may be of critical importance in the final outcome of neurodegeneration in neuroinflammatory diseases e.g. multiple sclerosis (MS). To provide insight into this process, we examined the migratory capacity of human monocyte-derived M1 and M2 polarised macrophages towards chemoattractants, relevant for neuroinflammatory diseases like MS.

1 January 2015 in Journal of Neuropathology & Experimental Neurology
Verified
Journal Article
Open access
PDF file
LPLaura Anna Norma Peferoen
Laura Anna Norma Peferoen
DVDaphne Y.S. Vogel
Daphne Y.S. Vogel
KUKimberley Ummenthum
Kimberley Ummenthum
MBMarjolein Breur
Marjolein Breur
PHPriscilla D.A.M. Heijnen
Priscilla D.A.M. Heijnen
SASandra Amor
Sandra Amor
Similar to macrophages, microglia adopt diverse activation states and contribute to repair and tissue damage in multiple sclerosis. Using reverse tran

10 March 2015 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
DVDaphne Y. S. Vogel
Daphne Y. S. Vogel
GKGijs Kooij
Gijs Kooij
PHPriscilla D. A. M. Heijnen
Priscilla D. A. M. Heijnen
MBMarjolein Breur
Marjolein Breur
LPLaura Anna Norma Peferoen
Laura Anna Norma Peferoen
CDChristine D. Dijkstra
Christine D. Dijkstra
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system (CNS). Infiltration of monocytes into the CNS is crucial for disease onset and progression. Animal studies indicate that granulocyte‐macrophages colony‐stimulating factor (GM‐CSF) may play an essential role in this process, possibly by acting on the migratory capacities of myeloid cells across the blood–brain barrier. This study describes the effect of GM‐CSF on human monocytes, macrophages, and microglia. Furthermore, the expression of GM‐CSF and its receptor was investigated in the CNS under healthy and pathological conditions. We show that GM‐CSF enhances monocyte migration across human blood–brain barrier endothelial cells in vitro. Next, immunohistochemical analysis on human brain tissues revealed that GM‐CSF is highly expressed by microglia and macrophages in MS lesions. The GM‐CSF receptor is expressed by neurons in the rim of combined gray/white matter lesions and astrocytes. Finally, the effect of GM‐CSF on human macrophages was determined, revealing an intermediate activation status, with a phenotype similar to that observed in active MS lesions. Together our data indicate that GM‐CSF is a powerful stimulator of monocyte migration, and is abundantly present in the inflamed CNS where it may act as an activator of macrophages and microglia.